Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.656
-0.022 (-3.26%)
At close: Nov 20, 2024, 4:00 PM
0.650
-0.006 (-0.93%)
Pre-market: Nov 21, 2024, 7:41 AM EST

Ensysce Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
4.422.232.523.533.931.76
Revenue Growth (YoY)
40.41%-11.61%-28.54%-10.18%122.86%-
Cost of Revenue
7.597.5919.844.694.393.4
Gross Profit
-3.17-5.36-17.31-1.16-0.46-1.64
Selling, General & Admin
5.085.366.9118.711.156.93
Operating Expenses
3.145.366.9118.711.156.93
Operating Income
-6.31-10.72-24.22-19.87-1.61-8.57
Interest Expense
-1.62-0.35-1.25-3.22-1-0.96
Other Non Operating Income (Expenses)
0.010.3-0.53-2.912.45-0.58
EBT Excluding Unusual Items
-7.93-10.77-26-26-0.16-10.1
Other Unusual Items
-0.151.79-3.15--
Pretax Income
-7.93-10.63-24.21-29.15-0.16-10.1
Earnings From Continuing Operations
-7.93-10.63-24.21-29.15-0.16-10.1
Minority Interest in Earnings
00.010.040.060.22-
Net Income
-7.93-10.61-24.17-29.080.06-10.1
Preferred Dividends & Other Adjustments
00.010.910.8--
Net Income to Common
-7.93-10.63-25.09-29.890.06-10.1
Shares Outstanding (Basic)
620001
Shares Outstanding (Diluted)
620001
Shares Change (YoY)
285.29%1158.34%114.15%22.15%-93.11%-
EPS (Basic)
-1.22-4.69-139.42-355.720.86-10.12
EPS (Diluted)
-1.22-4.69-139.42-355.720.84-10.12
Free Cash Flow
-8.54-10.78-17.89-8.24-1.25-0.94
Free Cash Flow Per Share
-1.32-4.76-99.42-98.10-18.13-0.94
Gross Margin
-71.61%-240.17%--32.82%-11.66%-92.88%
Operating Margin
-142.70%-480.52%-959.91%-562.71%-41.04%-485.74%
Profit Margin
-179.29%-476.39%-994.12%-846.37%1.44%-572.70%
Free Cash Flow Margin
-193.16%-483.29%-708.87%-233.41%-31.73%-53.02%
EBITDA
---24.22-19.87-1.61-8.57
EBITDA Margin
-----41.03%-
D&A For EBITDA
--0000
EBIT
-6.31-10.72-24.22-19.87-1.61-8.57
EBIT Margin
-142.70%----41.04%-
Source: S&P Capital IQ. Standard template. Financial Sources.